Tuesday, 04 Nov 2025

MedPulse360

AJMC® in the Press, August 8, 2025
12 August, 2025

A Personalized Approach: Considerations for Appropriate Biologic Selection in Hidradenitis Suppurativa
12 August, 2025

Right Therapy, Right Time: Guiding MS Treatment Amid Advancing Options
12 August, 2025

Modeling the Cost of Progression: Capturing the True Burden of MS
12 August, 2025

The Role of Biologics for Treatment of Hidradenitis Suppurativa
12 August, 2025

5 Hot FDA Approval Dates That Made Waves Across Therapeutic Areas in July
12 August, 2025

Emerging MS Treatments Offer New Hope for Progressive Disease
12 August, 2025

Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
12 August, 2025

Insulin Fills Declined as Costs Rose, With Persistent Gaps by Income: Elise S. Tremblay, MD, MPH
11 August, 2025

Advancing Equitable Access to Targeted and Immuno-Oncology Therapies in SCLC: Angel Qin, MD
11 August, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago